Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Carboxyhemoglobin | 1 | 2021 | 34 | 0.91 | Why? |
| Sleep Apnea, Obstructive | 2 | 2019 | 668 | 0.86 | Why? |
| alpha-Defensins | 1 | 2020 | 35 | 0.86 | Why? |
| Uvula | 1 | 2019 | 7 | 0.82 | Why? |
| Pulmonary Surfactant-Associated Protein D | 1 | 2020 | 129 | 0.76 | Why? |
| Malocclusion, Angle Class III | 1 | 2018 | 9 | 0.74 | Why? |
| Phosphorus | 1 | 2018 | 80 | 0.74 | Why? |
| Interleukin-18 | 1 | 2020 | 328 | 0.73 | Why? |
| Orthognathic Surgical Procedures | 1 | 2018 | 16 | 0.72 | Why? |
| Functional Laterality | 1 | 2018 | 57 | 0.72 | Why? |
| Lead | 1 | 2018 | 94 | 0.71 | Why? |
| Maxilla | 1 | 2018 | 70 | 0.69 | Why? |
| Macrophage Activation Syndrome | 2 | 2021 | 342 | 0.68 | Why? |
| Silicosis | 2 | 2018 | 20 | 0.67 | Why? |
| Occupational Health Services | 1 | 2020 | 219 | 0.66 | Why? |
| Chemokine CCL2 | 1 | 2019 | 389 | 0.66 | Why? |
| Respiratory Physiological Phenomena | 1 | 2018 | 157 | 0.64 | Why? |
| Textile Industry | 1 | 2015 | 11 | 0.62 | Why? |
| Mean Platelet Volume | 1 | 2017 | 203 | 0.60 | Why? |
| Pneumonectomy | 1 | 2018 | 278 | 0.59 | Why? |
| Sleep | 2 | 2018 | 2695 | 0.57 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 317 | 0.56 | Why? |
| Respiration | 1 | 2018 | 729 | 0.48 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.47 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 1165 | 0.47 | Why? |
| Turkey | 8 | 2021 | 3937 | 0.45 | Why? |
| Occupational Exposure | 4 | 2020 | 4742 | 0.44 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.44 | Why? |
| Pharynx | 1 | 2018 | 1544 | 0.41 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2021 | 3607 | 0.39 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 896 | 0.39 | Why? |
| Workplace | 1 | 2020 | 2075 | 0.35 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.32 | Why? |
| Vitamin D | 1 | 2020 | 2904 | 0.28 | Why? |
| Rheumatic Diseases | 1 | 2020 | 2675 | 0.28 | Why? |
| Coronary Artery Disease | 1 | 2019 | 2570 | 0.27 | Why? |
| Lung Neoplasms | 2 | 2018 | 3228 | 0.27 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.25 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.24 | Why? |
| Pulmonary Embolism | 2 | 2017 | 4775 | 0.22 | Why? |
| Serum Amyloid P-Component | 1 | 2021 | 193 | 0.20 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.20 | Why? |
| Agricultural Workers' Diseases | 1 | 2018 | 16 | 0.19 | Why? |
| Respiratory Tract Diseases | 2 | 2018 | 1061 | 0.19 | Why? |
| Osteotomy, Sagittal Split Ramus | 1 | 2018 | 1 | 0.19 | Why? |
| Osteotomy, Le Fort | 1 | 2018 | 10 | 0.19 | Why? |
| Mutation | 1 | 2019 | 12376 | 0.19 | Why? |
| Heterozygote | 1 | 2019 | 249 | 0.18 | Why? |
| Homozygote | 1 | 2019 | 230 | 0.18 | Why? |
| Silicon Dioxide | 1 | 2018 | 131 | 0.18 | Why? |
| Pesticides | 1 | 2018 | 100 | 0.17 | Why? |
| Cone-Beam Computed Tomography | 1 | 2018 | 118 | 0.17 | Why? |
| Lung | 4 | 2018 | 31049 | 0.17 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.17 | Why? |
| Mutation Rate | 1 | 2019 | 382 | 0.16 | Why? |
| Absenteeism | 1 | 2018 | 287 | 0.16 | Why? |
| Genetic Association Studies | 1 | 2019 | 559 | 0.15 | Why? |
| Work | 1 | 2018 | 342 | 0.15 | Why? |
| Case-Control Studies | 3 | 2019 | 17671 | 0.15 | Why? |
| Echocardiography, Doppler | 1 | 2017 | 269 | 0.15 | Why? |
| Trace Elements | 1 | 2018 | 284 | 0.14 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.14 | Why? |
| Male | 17 | 2021 | 367725 | 0.14 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.13 | Why? |
| Predictive Value of Tests | 2 | 2020 | 9537 | 0.13 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.12 | Why? |
| DNA | 1 | 2018 | 778 | 0.12 | Why? |
| Female | 16 | 2021 | 380317 | 0.12 | Why? |
| Risk Management | 1 | 2020 | 1044 | 0.12 | Why? |
| Safety | 1 | 2020 | 1583 | 0.12 | Why? |
| Respiratory Function Tests | 2 | 2018 | 1755 | 0.12 | Why? |
| Population Surveillance | 2 | 2021 | 4967 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| Safety Management | 1 | 2020 | 1093 | 0.12 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Tissue Plasminogen Activator | 1 | 2017 | 778 | 0.11 | Why? |
| Air Travel | 1 | 2018 | 585 | 0.11 | Why? |
| Platelet Count | 1 | 2017 | 1381 | 0.11 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3832 | 0.11 | Why? |
| Disease Progression | 3 | 2021 | 13580 | 0.10 | Why? |
| Humans | 22 | 2021 | 930598 | 0.10 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.10 | Why? |
| Adult | 10 | 2021 | 244371 | 0.09 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.09 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.09 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.09 | Why? |
| Radiography | 1 | 2015 | 1576 | 0.08 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.08 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
| Computed Tomography Angiography | 1 | 2017 | 2153 | 0.08 | Why? |
| Sleep Wake Disorders | 1 | 2018 | 1463 | 0.08 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.08 | Why? |
| Thrombolytic Therapy | 1 | 2017 | 2218 | 0.08 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2019 | 4027 | 0.07 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.07 | Why? |
| Aged | 7 | 2021 | 215776 | 0.07 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.07 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Occupational Diseases | 1 | 2017 | 2787 | 0.06 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2017 | 5993 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.05 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Time Factors | 3 | 2018 | 31397 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Gossypium | 1 | 2018 | 25 | 0.05 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.05 | Why? |
| Hospital Mortality | 2 | 2017 | 22087 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Pulmonary Gas Exchange | 1 | 2018 | 414 | 0.04 | Why? |
| Alleles | 1 | 2021 | 1557 | 0.04 | Why? |
| Agriculture | 1 | 2018 | 367 | 0.04 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.03 | Why? |
| Chemokine CXCL10 | 1 | 2018 | 565 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Incidence | 1 | 2015 | 25622 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Prevalence | 1 | 2015 | 25773 | 0.03 | Why? |
| Sputum | 1 | 2018 | 1720 | 0.03 | Why? |
| Dendritic Cells | 1 | 2018 | 1330 | 0.02 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.02 | Why? |
| Genotype | 1 | 2021 | 4697 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Continuity of Patient Care | 1 | 2018 | 1574 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.02 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.02 | Why? |
| Particulate Matter | 1 | 2018 | 3249 | 0.02 | Why? |
| Fibrinolytic Agents | 1 | 2017 | 1702 | 0.02 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Health Status | 1 | 2018 | 3259 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2018 | 3629 | 0.02 | Why? |
| Hypoxia | 1 | 2018 | 3626 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.01 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.01 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.01 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Akgün's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(168)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_